Germany is just one of the leading gamers in the global point-of-care glucose testing market. It has a big populace of type-1 and also type-2 diabetes mellitus people who are constantly opting for glucose screening, driving the market. The overall Germany point-of-care glucose testing market is divided into product type, application, and also end customer. The product kind uses lancing devices and strips, blood-glucose meter, whereas the application consists of type-1 diabetes as well as type-2 diabetes mellitus. End-user sector includes healthcare facilities and centers, home treatment setups, as well as others.
ise in prevalence of diabetes among individuals in Germany has driven the market for point-of-care glucose testing. As per the World Health Organization's recently released report, the number of individuals with diabetes mellitus in Germany increased from around 6.6 million in 2016 to 7 million in 2020. This surge in number of people with diabetic issues has resulted in rise in demand for precise glucose testing. In addition, boost in awareness among people toward diabetes and related health issues has driven the market. Furthermore, advent of technologies such as cellphones & healthcare applications has made the glucose testing procedure less complex, quick, and more convenient, thus augmenting the market growth. Moreover, beneficial reimbursement plans in the country have propelled the uptake of this technology.
However, there are certain restraints for the market. One of the key restraints is high price of glucose testing devices and their consumables. In addition, lack of understanding among public concerning these innovations is anticipated to hamper the development of the market. This is attributed to the complicated nature of testing procedure, which prevents numerous people from using these services.
The population in Germany is adversely affected by diabetes and health issues associated with it. This has necessitated the demand for effective therapy and diagnosis. Hence, the Germany point-of-care glucose testing market is expected to witness substantial growth in the coming years. Furthermore, increase in awareness about diabetes mellitus as well as its associated risks and surge in penetration of advanced products in the market are anticipated to drive its growth. Moreover, surge in number of diabetes-related research study programs and government-backed campaigns to increase awareness about diabetes is expected to boost the market development.
The Germany point-of-care glucose testing market is expected to experience surge in demand for precise testing equipment in the coming years. In addition, innovation in products such as the introduction of mobile healthcare applications and mobile glucose monitoring devices are anticipated to drive the market. Furthermore, businesses in the market are projected to concentrate on developing ingenious options to make glucose testing effortless and precise.
Moreover, firms are expected to focus on increasing their geographical existence to tap into the untapped potential in the remote locations of the country. Furthermore, federal government efforts such as offering aids to people suffering from diabetes mellitus and tax obligation rebates on testing equipment are anticipated to propel the adoption of these modern technologies. In addition, companies are projected to concentrate on expanding their product portfolio by introducing cutting-edge products and establishing partnerships with scientific institutes as well as other stakeholders such as doctors & suppliers in the future.
Several companies operating in the Germany point-of-care glucose testing market concentrate on product advancement and invest in R&D to stay competitive and gain a strong foothold. Businesses such as Roche, Abbott, Medtronic, Siemens Healthineers, Bayer, Novo Nordisk, PENTAX Medical, OptiMedis, ZEISS Team, and B. Braun Melsungen AG have undertaken various approaches in the last four years such as services & product launches, purchases, company expansions, partnerships, and investments.
Moreover, these businesses have adopted numerous advertising strategies to enhance their end-user perception. These consist of launching attractive projects and performing promotional activities to make consumers aware about their product or services. Furthermore, businesses are competing on the basis of price method by offering price cuts and promotional deals to tap large consumer base.
In addition, a few of the recent launches by these companies include Pentax Medical's Wireless Digital Sugar Meter, OptiMedis' Basic Glucose Meter, and Zeiss Group's Accu-Check Mobile Glucometer. These businesses are concentrating on collaborations with biotechnology firms, introducing sophisticated technological products, and purchasing startups to expand their product portfolio.
Five new arising firms in the Germany point-of-care glucose testing market consist of Terafleet GmbH, Winetech Innovations GmbH, Blend Bodytech, PreScan Diagnostics GmbH, and AI Pharma GmbH. These companies are concentrating on developing cutting-edge services to satisfy the demand for precise and practical glucose testing. In addition, few companies are concentrating on collaborations with numerous research study labs and scientific institutions to come up with advanced options for glucose testing in the near future.
Key Benefits For Stakeholders
- Enable informed decision-making process and offer market analysis based on current market situation and estimated future trends.
- Analyze the key strategies adopted by major market players in Germany point-of-care glucose testing market.
- Assess and rank the top factors that are expected to affect the growth of Germany point-of-care glucose testing market.
- Top Player positioning provides a clear understanding of the present position of market players.
- Detailed analysis of the Germany point-of-care glucose testing market segmentation assists to determine the prevailing market opportunities.
- Identify key investment pockets for various offerings in the market.
Germany Point-of-Care Glucose Testing Market Report Highlights
| Aspects | Details |
 Forecast period | 2022 - 2032 |
 Report Pages | 84 |
 By Product Type |
|
 By Application |
|
 By End User |
|
 Key Market Players | Siemens Healthineers, ZEISS Group, Pentax Medical, OptiMedis, B. Braun Melsungen AG, Novo Nordisk, Roche, Bayer, Abbott, Medtronic |
The Germany Point-of-Care Glucose Testing Market is projected to grow at a CAGR of 5% from 2022 to 2032
Roche, Abbott, Medtronic, Siemens Healthineers, Bayer, Novo Nordisk, Pentax Medical, OptiMedis, ZEISS Group, B. Braun Melsungen AG are the leading players in Germany Point-of-Care Glucose Testing Market
1. Enable informed decision-making process and offer market analysis based on current market situation and estimated future trends.
2. Analyze the key strategies adopted by major market players in germany point-of-care glucose testing market.
3. Assess and rank the top factors that are expected to affect the growth of germany point-of-care glucose testing market.
4. Top Player positioning provides a clear understanding of the present position of market players.
5. Detailed analysis of the germany point-of-care glucose testing market segmentation assists to determine the prevailing market opportunities.
6. Identify key investment pockets for various offerings in the market.
Germany Point-of-Care Glucose Testing Market is classified as by product type, by application, by end user
Loading Table Of Content...
Loading Research Methodology...
